Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 11, Issue 1
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Immunotherapy biomarkers
Original research
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Online download statistics by month:
Online download statistics by month: January 2023 to March 2024
Abstract
Full
Pdf
Jan 2023
601
607
182
Feb 2023
195
197
74
Mar 2023
130
130
51
Apr 2023
137
138
47
May 2023
99
99
27
Jun 2023
120
120
29
Jul 2023
132
132
43
Aug 2023
172
171
38
Sep 2023
121
122
43
Oct 2023
114
118
39
Nov 2023
133
134
53
Dec 2023
90
91
35
Jan 2024
61
61
35
Feb 2024
107
109
40
Mar 2024
144
146
82
Total
2356
2375
818
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF